THAP9 and esophageal squamous cell carcinoma: THAP9-AS1 expression was positively correlated with advanced tumor stages and poor prognosis; knockdown of THAP9-AS1 suppressed cell proliferation and invasion and enhanced apoptosis in esophageal squamous cell carcinoma (ESCC) [11].